Heli Malm

Summary

Affiliation: Helsinki University Central Hospital
Country: Finland

Publications

  1. doi request reprint Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome
    Heli Malm
    Teratology Information, HUSLAB and Helsinki University Central Hospital, Helsinki, Finland
    Ther Drug Monit 34:607-14. 2012
  2. pmc Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI)
    Heli Malm
    Teratology Information, HUSLAB and Helsinki University Central Hospital, Tukholmankatu 17, P, O, Box 790, 00029 HUS, Helsinki, Finland
    BMC Psychiatry 12:217. 2012
  3. ncbi request reprint Prescription drugs during pregnancy and lactation--a Finnish register-based study
    Heli Malm
    Department of Medical Genetics, The Family Federation of Finland, Helsinki, Finland
    Eur J Clin Pharmacol 59:127-33. 2003
  4. ncbi request reprint Prescription of hazardous drugs during pregnancy
    Heli Malm
    Teratology Information Service, Helsinki University Central Hospital, Helsinki, Finland
    Drug Saf 27:899-908. 2004
  5. ncbi request reprint Risks associated with selective serotonin reuptake inhibitors in pregnancy
    Heli Malm
    Teratology Information Service, HUSLAB, Helsinki University Central Hospital, Finland
    Obstet Gynecol 106:1289-96. 2005
  6. doi request reprint Selective serotonin reuptake inhibitors and risk for major congenital anomalies
    Heli Malm
    Teratology Information Service, Helsinki University Central Hospital and HUSLAB, Helsinki, Finland
    Obstet Gynecol 118:111-20. 2011
  7. doi request reprint Nationwide register-based surveillance system on drugs and pregnancy in Finland 1996-2006
    Miia Artama
    National Institute for Health and Welfare, THL, Helsinki, Finland
    Pharmacoepidemiol Drug Saf 20:729-38. 2011
  8. doi request reprint Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs)
    Maria Ellfolk
    Teratology Information Service, Helsinki University Central Hospital and HUSLAB, Helsinki, Finland
    Reprod Toxicol 30:249-60. 2010
  9. doi request reprint Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland
    Miia Artama
    National Institute for Health and Welfare, PO Box 30, 00271 Helsinki, Finland
    Drug Saf 36:359-69. 2013
  10. doi request reprint Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy
    Adrienne Einarson
    Motherisk Program, Hospital for Sick Children, Division of Clinical Pharmacology, University of Toronto, 555 University Ave, Toronto, Ontario M5G 1X8, Canada
    Am J Psychiatry 165:749-52. 2008

Collaborators

Detail Information

Publications13

  1. doi request reprint Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome
    Heli Malm
    Teratology Information, HUSLAB and Helsinki University Central Hospital, Helsinki, Finland
    Ther Drug Monit 34:607-14. 2012
    ..The selective serotonin reuptake inhibitors are prescribed increasingly also during pregnancy. Although a number of studies have assessed their safety, data concerning congenital malformations and adverse perinatal outcome are conflicting...
  2. pmc Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI)
    Heli Malm
    Teratology Information, HUSLAB and Helsinki University Central Hospital, Tukholmankatu 17, P, O, Box 790, 00029 HUS, Helsinki, Finland
    BMC Psychiatry 12:217. 2012
    ..We describe the methods and design of a population-based study examining the association between prenatal SSRI exposure and neurodevelopment until age 14...
  3. ncbi request reprint Prescription drugs during pregnancy and lactation--a Finnish register-based study
    Heli Malm
    Department of Medical Genetics, The Family Federation of Finland, Helsinki, Finland
    Eur J Clin Pharmacol 59:127-33. 2003
    ..To examine the use of prescription drugs in Finnish women before and during pregnancy and lactation...
  4. ncbi request reprint Prescription of hazardous drugs during pregnancy
    Heli Malm
    Teratology Information Service, Helsinki University Central Hospital, Helsinki, Finland
    Drug Saf 27:899-908. 2004
    ..Prescribing drugs to pregnant women requires the balancing of benefits and risks. Only a small proportion of drugs are known to be harmful to the fetus, but for the vast majority of drugs little evidence of fetal safety exists...
  5. ncbi request reprint Risks associated with selective serotonin reuptake inhibitors in pregnancy
    Heli Malm
    Teratology Information Service, HUSLAB, Helsinki University Central Hospital, Finland
    Obstet Gynecol 106:1289-96. 2005
    ..To study the effects of selective serotonin reuptake inhibitors (SSRIs) on pregnancy outcome...
  6. doi request reprint Selective serotonin reuptake inhibitors and risk for major congenital anomalies
    Heli Malm
    Teratology Information Service, Helsinki University Central Hospital and HUSLAB, Helsinki, Finland
    Obstet Gynecol 118:111-20. 2011
    ..To estimate the risk of major congenital anomalies after exposure to selective serotonin reuptake inhibitors during pregnancy...
  7. doi request reprint Nationwide register-based surveillance system on drugs and pregnancy in Finland 1996-2006
    Miia Artama
    National Institute for Health and Welfare, THL, Helsinki, Finland
    Pharmacoepidemiol Drug Saf 20:729-38. 2011
    ....
  8. doi request reprint Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs)
    Maria Ellfolk
    Teratology Information Service, Helsinki University Central Hospital and HUSLAB, Helsinki, Finland
    Reprod Toxicol 30:249-60. 2010
    ..Prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) may increase risk for congenital malformations and adverse perinatal outcome...
  9. doi request reprint Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland
    Miia Artama
    National Institute for Health and Welfare, PO Box 30, 00271 Helsinki, Finland
    Drug Saf 36:359-69. 2013
    ..Antiepileptic drugs (AEDs) pass through the placenta and may affect neonatal outcome...
  10. doi request reprint Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy
    Adrienne Einarson
    Motherisk Program, Hospital for Sick Children, Division of Clinical Pharmacology, University of Toronto, 555 University Ave, Toronto, Ontario M5G 1X8, Canada
    Am J Psychiatry 165:749-52. 2008
    ..In this study, the authors sought to determine whether paroxetine was associated with an increased risk of cardiovascular defects in infants of women exposed to the drug during the first trimester of pregnancy...
  11. ncbi request reprint Pregnancy outcome of women exposed to azathioprine during pregnancy
    Lee Hilary Goldstein
    Clinical Pharmacology Unit, Teratogen Information Service, Assaf Harofeh Medical Center, Sackler School of Medicine, Tel Aviv University, Israel
    Birth Defects Res A Clin Mol Teratol 79:696-701. 2007
    ..Our objective was too determine whether exposure to AZP during pregnancy increases the risk for major malformations and to determine the effect on pregnancy outcome...
  12. ncbi request reprint Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors
    Benjamin Bar-Oz
    Motherisk Program, The Hospital for Sick Children, Toronto, Ontario, Canada
    Clin Ther 29:918-26. 2007
    ..Antidepressants have been commonly used by women of childbearing age. Recent studies suggest that paroxetine, a selective serotonin reuptake inhibitor (SSRI), might specifically increase teratogenic risk...
  13. doi request reprint The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study
    Corinna Weber-Schoendorfer
    Pharmakovigilanz und Beratungszentrum für Embryonaltoxikologie, BBGes, Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Spandauer Damm 130, Haus 10, 14050 Berlin, Germany
    Reprod Toxicol 26:24-30. 2008
    ..To assess the safety of calcium channel blockers during the first trimester of pregnancy...